These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8413595)

  • 21. Wyeth responds to criticism.
    Stiles GM
    Md Med; 2005; 6(4):5, 7-8; author reply 8. PubMed ID: 16454430
    [No Abstract]   [Full Text] [Related]  

  • 22. Biotech boom.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 24. Fair vaccine pricing please, not random acts of charity.
    Torreele E; Mazzucato M
    BMJ; 2016 Nov; 355():i6173. PubMed ID: 27881408
    [No Abstract]   [Full Text] [Related]  

  • 25. [Survival or decline of the pharmaceutical industry?].
    Schwob M
    Nouv Presse Med; 1980 Jan; 9(3):148. PubMed ID: 7355096
    [No Abstract]   [Full Text] [Related]  

  • 26. What have been the strategies for the registration, positioning and control of medical information for intramuscular artemether?
    Helenport JP; Roche G
    Med Trop (Mars); 1998; 58(3 Suppl):73-6. PubMed ID: 10212906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
    Kesselheim AS
    Clin Pharmacol Ther; 2009 Jun; 85(6):573-5. PubMed ID: 19451908
    [No Abstract]   [Full Text] [Related]  

  • 29. BIO 2006 Annual International Convention. The expanding biotech industry of France.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
    [No Abstract]   [Full Text] [Related]  

  • 30. [Public health and chemical-pharmaceutical companies].
    Ribeiro MA
    Hist Cienc Saude Manguinhos; 2000 Nov-2001 Feb; 7(3):607-26. PubMed ID: 16683337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 33. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financing vaccines: in search of solutions that work.
    Iglehart JK
    Health Aff (Millwood); 2005; 24(3):594-5. PubMed ID: 15886147
    [No Abstract]   [Full Text] [Related]  

  • 35. Charity launches not-for-profit drug industry.
    Butler D
    Nature; 2002 Apr; 416(6880):465. PubMed ID: 11932709
    [No Abstract]   [Full Text] [Related]  

  • 36. France lays plans for premier cancer centre in Toulouse.
    Abbott A
    Nature; 2005 Mar; 434(7029):5. PubMed ID: 15744258
    [No Abstract]   [Full Text] [Related]  

  • 37. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The perils of federalizing vaccine production.
    Kazman S; Miller HI
    Nat Biotechnol; 2002 Feb; 20(2):113. PubMed ID: 11821845
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 40. Chiron flu flap suggests vaccine industry needs shot in the arm.
    Singer E
    Nat Med; 2004 Nov; 10(11):1148. PubMed ID: 15516895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.